Pablo Amaya

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Identification of siRNA delivery enhancers by a chemical library screen

Jérôme Gilleron, Prasath Paramasivam, Anja Zeigerer et al. · Nucleic Acids Research · 2015 · 69 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Fighting Against Stroke in Latin America: A Joint Effort of Medical Professional Societies and Governments

Sheila Cristina Ouriques Martins, Pablo M. Lavados, Thaís Secchi et al. · Frontiers in Neurology · 2021 · 46 citations · Full text

Public Affairs, Health Policy, Global Health +12

Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19

João Pedro Marto, Davide Strambo, George Ntaios et al. · Neurology · 2022 · 31 citations · Full text

Medicine, Infectious Diseases, Interventional Cardiology +16

Regional and national differences in stroke thrombolysis use and disparities in pricing, treatment availability, and coverage

Ana Cláudia de Souza, Ivy Sebastian, Wan Asyraf Wan Zaidi et al. · International Journal of Stroke · 2022 · 28 citations

Social Sciences, Economics, Health Policy +17